S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money

Pyxis Oncology (PYXS) SEC Filings & 10K Form

$4.92
-0.35 (-6.64%)
(As of 04/12/2024 ET)

Recent Pyxis Oncology SEC Filings

DateFilerForm TypeView
04/03/2024
11:15 PM
Pyxis Oncology (Filer)
Form EFFECT
03/28/2024
3:31 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:32 PM
Civik Thomas (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:32 PM
HUMPHREY RACHEL (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Cline Darren S (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:49 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
6:44 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
3:54 PM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:45 PM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2024
3:31 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:02 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:28 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pyxis Oncology (Subject)
Form SC 13G/A
12/29/2023
3:33 PM
Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:50 PM
Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/28/2023
6:22 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:44 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
3:46 PM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2023
3:34 PM
Pyxis Oncology (Filer)
Form 8-K/A
09/28/2023
3:32 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
5:36 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
5:37 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
6:04 PM
Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
4:05 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
4:04 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:34 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:35 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
6:03 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:26 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2023
3:43 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
7:16 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:47 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2023
3:35 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
3:46 PM
Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
4:08 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
4:28 PM
Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/25/2023
4:30 PM
Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
11:15 PM
Pyxis Oncology (Filer)
Form EFFECT
08/23/2023
4:28 PM
Pyxis Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/23/2023
4:28 PM
Pyxis Oncology (Filer)
Form POS AM
Automatic Income (from home) (Ad)

For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year.

Just click here now to watch my presentation for free.
08/23/2023
4:30 PM
Pyxis Oncology (Filer)
Form S-8 POS
08/23/2023
7:47 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
4:00 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
6:25 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
6:26 AM
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
Form 425
08/11/2023
6:31 AM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2023
5:34 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
5:35 AM
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
Form 425
07/31/2023
3:41 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/28/2023
9:18 AM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144/A
07/21/2023
3:27 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2023
12:27 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2023
11:15 PM
Pyxis Oncology (Filer)
Form EFFECT
06/30/2023
3:30 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
3:31 PM
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
Form 425
06/16/2023
2:22 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
7:03 AM
Pyxis Oncology (Filer)
Form S-4
Registration statement under Securities Act of 1933  
06/07/2023
6:12 PM
Feingold Jay (Reporting)
Pyxis Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2023
3:41 PM
Pyxis Oncology (Subject)
Form 425
05/25/2023
7:14 AM
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
Form 425
05/24/2023
5:59 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
6:03 AM
Pyxis Oncology (Subject)
Form 425
05/24/2023
6:05 AM
Apexigen, Inc. (Filed by)
Apexigen, Inc. (Filed by)
Apexigen, Inc. (Filed by)
Pyxis Oncology (Subject)
Form 425
05/11/2023
6:16 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
6:19 AM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2023
3:25 PM
Pyxis Oncology (Filer)
Form DEF 14A
04/28/2023
3:28 PM
Pyxis Oncology (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PYXS) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners